Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1965 1
1967 1
1968 2
1977 1
1983 1
1985 2
1989 1
1990 1
1992 1
1994 1
1996 2
2001 1
2004 2
2007 1
2008 1
2010 2
2011 1
2015 2
2016 2
2019 2
2020 2
2021 1
2022 2
2023 2
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Yellow fever in South America - A plea for action and call for prevention also in travelers from SLAMVI, ESGITM, EVASG, ALEIMC, GEPI-SEIMC, SEMEVI, and CMTZMV-ACIN.
Rodriguez-Morales AJ, Alhazmi AH, Katime A, Hameed AA, Morales A, Lepetic AC, Risquez A, Forero-Delgadillo AJ, Holguin A, Faccini-Martínez ÁA, Guerrero A, Ribeiro A, Al Balushi A, Taylan Ozkan A, Rathish B, Diaz B, Porras-Pedroza BE, Hunsajarupan B, Lakatos B, Álvarez-Moreno C, Torres-Martinez CN, Ronnberg C, Perret C, Wejse CM, Adhikari A, Popescu CP, Abbara A, Biscayart C, Bonilla-Aldana DK, Fasan D, Calderon D, de Luna D, Forero-Peña DA, Costescu-Strachinaru DI, Mendes Pedro D, Monk EJM, Iliaki E, Pontali E, Ngbede EO, Farkas FB, González-Sanz M, Escarrá F, Mariotti F, Norman FF, Di Gennaro F, Membrillo FJ, Arrieta G, Guido G, Fuster ÁV, Grandez-Castillo GA, Leblebicioglu H, de Jong HK, Vargas H, Kim JA, Cardona-Ospina JA, Torres JR, Llenas-García J, Wagenhäuser I, Oteo JA, Gallegos Braun JF, Sepulveda-Arias JC, Hernandez JP, Ruíz Sáenz J, Nwofe JO, Kowalska J, Jackson KE, Aykac K, Rezzonico LF, Reyes LF, Frallonardo L, Krone M, Malagón MF, Sempere-Alcocer MA, Luque MT, Carlos M, Del Mar Faraco Oñorbe M, Segura Moreno M, Lauriola M, Masana M, Fernandez M, Martinez-Gutierrez M, Diaz-Menendez M, Martinez MJ, Cabada MM, Morante-Ruiz M, Alvarez-Martinez MJ, Sandoval-Paiz N, Chávez … See abstract for full author list ➔ Rodriguez-Morales AJ, et al. Travel Med Infect Dis. 2025 Sep-Oct;67:102871. doi: 10.1016/j.tmaid.2025.102871. Epub 2025 Jun 27. Travel Med Infect Dis. 2025. PMID: 40582475 Free article. No abstract available.
Isolated traumatic aniridia with full and partial iris expulsion in pseudophakic eyes.
Ichioka S, Ishida A, Sugihara K, Sano I, Tanito M. Ichioka S, et al. BMC Ophthalmol. 2022 Oct 1;22(1):390. doi: 10.1186/s12886-022-02615-4. BMC Ophthalmol. 2022. PMID: 36183072 Free PMC article.
A blood clot was present in the well-formed anterior chamber and expulsed iris tissue was seen beneath the conjunctiva. Exploratory surgery showed no scleral laceration other than the previous sclerocorneal tunnel. ...Exploratory surgery showed no scleral laceration and th …
A blood clot was present in the well-formed anterior chamber and expulsed iris tissue was seen beneath the conjunctiva. Exploratory s …
Beraprost and Overall Survival in Cats with Chronic Kidney Disease.
Ito H, Matsuura T, Sano T. Ito H, et al. Vet Sci. 2023 Jul 13;10(7):459. doi: 10.3390/vetsci10070459. Vet Sci. 2023. PMID: 37505864 Free PMC article.
Beraprost has been shown to reduce the kidney function decline in cats with International Renal Interest Society (IRIS) stage 2 and 3 CKD. However, the association with prolonged survival has not yet been examined. OBJECTIVE: To assess the relationship between beraprost an …
Beraprost has been shown to reduce the kidney function decline in cats with International Renal Interest Society (IRIS) stage 2 and 3 …
Intraoperative floppy-iris syndrome associated with use of antipsychotic drugs.
Matsuo M, Sano I, Ikeda Y, Fujihara E, Tanito M. Matsuo M, et al. Can J Ophthalmol. 2016 Aug;51(4):294-296. doi: 10.1016/j.jcjo.2016.02.008. Epub 2016 Jun 30. Can J Ophthalmol. 2016. PMID: 27521670
OBJECTIVE: We report 3 cases of intraoperative floppy-iris syndrome (IFIS) during cataract surgery in patients without a history of selective alpha1-blocker use but with a long-term history of antipsychotic drug use. ...
OBJECTIVE: We report 3 cases of intraoperative floppy-iris syndrome (IFIS) during cataract surgery in patients without a history of s …
Intra-operative challenges encountered using the zepto nano-pulse precision capsulotomy device.
Kalambe AS, Sano I, Sugihara K, Ishida A, Ichioka S, Shimada A, Tanito M. Kalambe AS, et al. Am J Ophthalmol Case Rep. 2023 Mar 31;30:101841. doi: 10.1016/j.ajoc.2023.101841. eCollection 2023 Jun. Am J Ophthalmol Case Rep. 2023. PMID: 37077294 Free PMC article.
During a planned phacoemulsification procedure, despite synechialysis for the 360 posterior synechiae, the iris tissue was sucked into the suction cup of the Zepto device and became incarcerated over the lens. ...
During a planned phacoemulsification procedure, despite synechialysis for the 360 posterior synechiae, the iris tissue was sucked in …
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).
Samura H, Oki E, Okumura H, Yoshida T, Kai S, Kobayashi K, Kinjo T, Mori S, Tohyama T, Ohgaki K, Kawanaka H, Makiyama A, Ureshino N, Kotaka M, Shimose T, Ando K, Saeki H, Baba H, Maehara Y, Mori M. Samura H, et al. Cancer Chemother Pharmacol. 2020 Aug;86(2):285-294. doi: 10.1007/s00280-020-04108-x. Epub 2020 Jul 30. Cancer Chemother Pharmacol. 2020. PMID: 32734398 Clinical Trial.
PURPOSE: This study was designed to assess the tolerability, efficacy, and safety of tri-weekly irinotecan plus S-1 (IRIS) and weekly cetuximab in patients with metastatic colorectal cancer (mCRC). METHODS: The main eligibility criteria were RAS wild-type mCRC with no prio …
PURPOSE: This study was designed to assess the tolerability, efficacy, and safety of tri-weekly irinotecan plus S-1 (IRIS) and weekly …
Chromatin dynamics associated with seed desiccation tolerance/sensitivity at early germination in Medicago truncatula.
Sano N, Malabarba J, Chen Z, Gaillard S, Windels D, Verdier J. Sano N, et al. Front Plant Sci. 2022 Nov 24;13:1059493. doi: 10.3389/fpls.2022.1059493. eCollection 2022. Front Plant Sci. 2022. PMID: 36507374 Free PMC article.
Finally, in order to make these comprehensive genome-wide analyses of transcript and chromatin dynamics useful to the scientific community working on early germination and DT, we generated a dedicated genome browser containing all these data and publicly available at https://i …
Finally, in order to make these comprehensive genome-wide analyses of transcript and chromatin dynamics useful to the scientific community w …
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis Inhibitor.
Yamazaki K, Yuki S, Oki E, Sano F, Makishima M, Aoki K, Hamano T, Yamanaka T. Yamazaki K, et al. Clin Colorectal Cancer. 2021 Sep;20(3):e173-e184. doi: 10.1016/j.clcc.2021.03.001. Epub 2021 Mar 8. Clin Colorectal Cancer. 2021. PMID: 33875364 Free article.
PATIENTS AND METHODS: This retrospective study evaluated the efficacy and safety of fluorouracil and irinotecan (FOLFIRI) plus ramucirumab (RAM); FOLFIRI plus aflibercept (AFL); irinotecan and S-1 (IRIS) plus bevacizumab (BEV); and capecitabine and irinotecan (CAPIRI) plus …
PATIENTS AND METHODS: This retrospective study evaluated the efficacy and safety of fluorouracil and irinotecan (FOLFIRI) plus ramucirumab ( …
Overall survival with beraprost in dogs with IRIS stage 2 chronic kidney disease.
Mayumi M, Matsuura T, Sano T. Mayumi M, et al. Front Vet Sci. 2026 Apr 24;13:1665061. doi: 10.3389/fvets.2026.1665061. eCollection 2026. Front Vet Sci. 2026. PMID: 42164767 Free PMC article.
Furthermore, beraprost therapy was associated with a significant delay in the time to secondary composite endpoints, including disease progression (to IRIS stage 3/4) or death (P = 0.001) and 10% body weight loss or death (P = 0.028), underscoring the robustness of the sur …
Furthermore, beraprost therapy was associated with a significant delay in the time to secondary composite endpoints, including disease progr …
36 results